Get Adobe Flash player

Harry Bushong

President and cofounder of nanoTox, Inc., Harry Bushong’s expertise includes work in the life sciences, raising capital for startups and leveraging value in intellectual property.

In 2003, Mr. Bushong worked with The Olmsted Group, a New York life sciences merchant bank with a licensed portfolio including Intellectual Property from Columbia University, Wisconsin University, MIT, Vanderbilt and Baylor College of Medicine in the fields of stem cells, genomics, biotech and hepatocytes. Mr. Bushong assisted several companies formed around a proprietary piece of intellectual property, including Omnimmune Corp., Plurion, Zirus (formerly Avatar), and Amphioxus. Amphioxus recently merged with Plurion to form Stem Cell Innovations, Inc. In addition, he worked with both public and private enterprises at Aurora Financial Services, a private NASD broker/dealer focused on the energy sector.

Mr. Bushong formed Wired Capital a private equity network series to assist early stage investors identify promising technological and industrial enterprises in Austin, Houston, Chicago, New York, San Francisco and Miami. He also helped transform a solutions management animation company into one of Austin’s earliest streaming media companies, securing three rounds of investments, a $3.5 Million encoding contract, and an international management team to promote the business model.

Mr. Bushong earned his National Association Of Securities Dealers Series 7 and 63 licenses while with Prudential Financial Services in Austin.

William Stahl
Chief Financial Officer

Certified Public Account William Stahl joined nanoTox in 2005 and has 34 years of experience in various companies and industries in increasingly complex financial management and accounting positions.

Prior to nanoTox, he had a private accounting practice and was CFO, Corporate Secretary and Corporate Treasurer for three separate start-up companies. Mr. Stahl was Senior Executive and CFO for an Austin, Texas-based indirect lender of consumer automobile contracts. Most notably, he led the Initial Public Offering of this firm, responsible for regulatory registrations and filings, negotiations and investment bankers. He managed all aspects of the firm’s financial operation and was instrumental in developing its financial and accounting infrastructure as it grew from 25 employees to over 125.

During Mr. Stahl’s ten years with the securities industry, he obtained Series 7 and Series 4 securities licenses and led the Financial Strategies support group of Westcap Securities serving more than 100 brokers primarily in asset-liability management for financial institutions.


Welcome To nanoTox

Alternative flash content

You need to upgrade your Flash Player

Get Adobe Flash player

Search Our Site
Published Articles

Fact Sheet for Nanotechnology under the Toxic Substances Control Act | Prevention, Pesticides and Toxics (OPPTS) | US EPA